Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2013

View Archived Issues

New milestone under Ono Pharmaceutical and Receptos' GPCR collaboration

Novel nanoparticles shown to suppress choroidal neovascularization

Sirolimus demonstrates safety in patients with uveitis

ADMA Biologics begins pivotal phase III study of RI-002 in PIDD

Hangzhou Bensheng Pharmaceutical divulges novel agents for cancer

GlaxoSmithKline synthesizes bromodomain-containing protein inhibitor

reMYND patents new agents for tauopathies

Janssen and Bayer launch global cardiovascular research program for Xarelto

Incyte Corp. prepares new series of JAK1 inhibitors

Vitamin D deficiency associated with psoriasis severity

New mutations identified in Gorlin-Goltz syndrome

Norendoxifen as a new lead compound for aromatase inhibitor development

Researchers at Piramal Imaging design new diagnostics for thrombosis

Cellceutix plans future Kevetrin trials

Merck & Co. submits BLA for ragweed AIT

Non-inferiority reported in phase III trial of the seasonal flu vaccine ASP-7374

Theravance grants Clinigen exclusive commercialization rights to Vibativ in the E.U.

Retrophin reports data from preclinical studies of RE-024

Amgen synthesizes novel sodium channel blockers

Aeterna Zentaris to stop phase III trial of combination regimen using perifosine

Sosei initiates phase III study of mucoadhesive buccal tablet for oropharyngeal candidiasis

ZIOPHARM Oncology begins phase II study of Ad-RTS IL-12 combined with palifosfamide

Autologous CDC therapy proves to be safe and effective in patients post-MI

TONIX Pharmaceuticals and the FDA discuss NDA plan for TNX-102

NeuroVive acquires novel cyclophilin inhibitors from Biotica

Astellas and Ambit terminate collaboration for FLT3 kinase inhibitors

Telormedix commences enrollment in phase II trial in bladder cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...